← FDA DRUG APPROVALS

FDA ANDA · ANDA062751

C-SOLVE-2

Sponsor: IVAX SUB TEVA PHARMS

APPLICATION
ANDA062751
TYPE
ANDA
ORIGINAL APPROVAL
1993-07-30
LATEST ACTION
2001-09-17
ROUTE
TOPICAL
DOSAGE FORM
SWAB
MARKETING STATUS
Discontinued

Products

C-SOLVE-2Discontinued
ERYTHROMYCIN 2% · SWAB · TOPICAL

Approval history

2001-09-17Labeling · Supplement 4AP
2001-09-17Manufacturing (CMC) · Supplement 3AP
1993-07-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →